Daniel A. Gipe
Impact in
- Surgery top 1%
- Lipoproteins and Cardiovascular Health
-
- Lipid metabolism and disorders
Papers in
- Surgery 17
- Lipoproteins and Cardiovascular Health 17
-
- Lipid metabolism and disorders 11
- Antiplatelet Therapy and Cardiovascular Diseases 1
- Co-authors
- Robert Pordy (16 shared papers)Marie T. Baccara‐Dinet (5 shared papers)John J.P. Kastelein (5 shared papers)G. Kees Hovingh (5 shared papers)Daniel Gaudet (12 shared papers)Kuo‐Chen Chan (9 shared papers)Poulabi Banerjee (6 shared papers)Yunling Du (2 shared papers)
- Journals
- Journal of clinical lipidology (6 papers)Atherosclerosis (5 papers)Circulation (2 papers)Arteriosclerosis Thrombosis and Vascular Biology (2 papers)European Heart Journal (2 papers)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Daniel A. Gipe
23 papers receiving 2.1k citations
Daniel A. Gipe's Hit Papers
Peers
Comparison fields: 5 of 63
- Surgery 1.6k
- Cardiology and Cardiovascular Medicine 644
- Endocrinology, Diabetes and Metabolism 417
- Cancer Research 320
- Economics and Econometrics 335
Countries citing papers authored by Daniel A. Gipe
This map shows the geographic impact of Daniel A. Gipe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Gipe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Gipe more than expected).
Fields of papers citing papers by Daniel A. Gipe
This network shows the impact of papers produced by Daniel A. Gipe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Gipe. The network helps show where Daniel A. Gipe may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel A. Gipe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Evinacumab for Homozygous Familial Hypercholesterolemia Hit paper breakdown → | 2020 | 503 |
| 2 | ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia Hit paper breakdown → | 2015 | 423 |
| 3 | Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial Hit paper breakdown → | 2015 | 349 |
| 4 | 2019 | 179 | |
| 5 | 2014 | 168 | |
| 6 | 2014 | 109 | |
| 7 | 2014 | 83 | |
| 8 | 2021 | 74 | |
| 9 | 2019 | 67 | |
| 10 | 2016 | 57 | |
| 11 | 2020 | 37 | |
| 12 | 2015 | 15 | |
| 13 | 2016 | 15 | |
| 14 | 2014 | 10 | |
| 15 | 2016 | 7 | |
| 16 | 2017 | 6 | |
| 17 | 2016 | 6 | |
| 18 | 2017 | 3 | |
| 19 | Abstract 19133: Inhibition of ANGPTL3 by Evinacumab Reduced Triglycerides (TGs) and LDL-C in Subjects Presenting With Modest Elevations in TGs and/or LDL-C, Recapitulating the Hypolipidemic Effects of Loss-of-Function (LoF) Mutations of ANGPTL3 | 2016 | 2 |
| 20 | 2017 | 2 |
About Daniel A. Gipe
Daniel A. Gipe is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Cancer Research, Economics and Econometrics and Nephrology, having authored 24 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (17 papers), Lipid metabolism and disorders (11 papers), Cancer, Lipids, and Metabolism (6 papers), Pharmaceutical Economics and Policy (3 papers), Renal Diseases and Glomerulopathies (2 papers), Health Systems, Economic Evaluations, Quality of Life (1 paper), Inflammatory mediators and NSAID effects (1 paper) and Antiplatelet Therapy and Cardiovascular Diseases (1 paper). The work is most often cited by research in Surgery (1.6k citations), Cardiology and Cardiovascular Medicine (644 citations), Endocrinology, Diabetes and Metabolism (417 citations), Cancer Research (320 citations) and Economics and Econometrics (335 citations). Daniel A. Gipe has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Robert Pordy, Marie T. Baccara‐Dinet, John J.P. Kastelein, G. Kees Hovingh, Daniel Gaudet, Kuo‐Chen Chan, Poulabi Banerjee, Yunling Du, Henry N. Ginsberg and Gisle Langslet. Their work appears in journals such as Journal of clinical lipidology, Atherosclerosis, Circulation, Arteriosclerosis Thrombosis and Vascular Biology and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.